A.L. Jackman
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 14
- Cancer Treatment and Pharmacology 4
- Rheumatology top 10%
-
- Biochemical and Molecular Research 11
- Cancer therapeutics and mechanisms 3
-
- Cancer, Hypoxia, and Metabolism 2
-
- Quinazolinone synthesis and applications 6
-
- Gastric Cancer Management and Outcomes 4
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- A H CalvertRosemary KimbellMelody BrownWilliam GibsonG. Wynne AherneAnthea HardcastleLloyd R. KèllandJenny Titley
- Journals
- British Journal of Cancer (4 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesIsrael
In The Last Decade
A.L. Jackman
23 papers receiving 813 citations
Peers
Comparison fields: 5 of 59
- Oncology 513
- Rheumatology 140
- Molecular Biology 503
- Cancer Research 74
- Hematology 52
Countries citing papers authored by A.L. Jackman
This map shows the geographic impact of A.L. Jackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Jackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Jackman more than expected).
Fields of papers citing papers by A.L. Jackman
This network shows the impact of papers produced by A.L. Jackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Jackman. The network helps show where A.L. Jackman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A.L. Jackman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2004 | 1 | |
| 3 | Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studies. | 2000 | 18 |
| 4 | Balb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicity. | 2000 | 20 |
| 5 | Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues. | 2000 | 66 |
| 6 | 1999 | 10 | |
| 7 | Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331 | 1998 | 1 |
| 8 | 1998 | 26 | |
| 9 | 1998 | 17 | |
| 10 | 1998 | 5 | |
| 11 | 1995 | 33 | |
| 12 | 1995 | 27 | |
| 13 | 1995 | 88 | |
| 14 | 1994 | 7 | |
| 15 | ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. | 1991 | 322 |
| 16 | 1987 | 26 | |
| 17 | Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717). | 1987 | 25 |
| 18 | 1986 | 3 | |
| 19 | BIOCHEMICAL DISTURBANCES OBSERVED INVITRO AND INVIVO FOLLOWING INHIBITION OF THYMIDYLATE SYNTHETASE BY C-3717 | 1982 | 1 |
| 20 | 2-AMINO-4-HYDROXY QUINAZOLINE ANALOGS OF FOLIC-ACID AS THYMIDYLATE SYNTHETASE INHIBITORS | 1979 | 1 |
About A.L. Jackman
A.L. Jackman is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Genetics and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 842 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Biochemical and Molecular Research (11 papers), Quinazolinone synthesis and applications (6 papers), Cancer Treatment and Pharmacology (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer therapeutics and mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (513 citations), Rheumatology (140 citations), Molecular Biology (503 citations), Cancer Research (74 citations) and Hematology (52 citations). A.L. Jackman has collaborated with scholars based in United Kingdom, United States and Israel. Frequent co-authors include A H Calvert, Rosemary Kimbell, Melody Brown, William Gibson, G. Wynne Aherne, Anthea Hardcastle, Lloyd R. Kèlland, Jenny Titley, Lisa Brunton and S. J. Harland. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Journal of Clinical Oncology, Cytometry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.